Danner, S A <br/><br/>
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group.  [electronic resource] 

 -  The New England journal of medicine  Dec 1995 
 - 1528-33 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-4793 
<br/><br/><label>Standard No.: </label>10.1056/NEJM199512073332303  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--adverse effects<br/>CD4 Lymphocyte Count--drug effects<br/>Double-Blind Method<br/>Female<br/>HIV Core Protein p24--blood<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--adverse effects<br/>HIV-1--drug effects<br/>Humans<br/>Male<br/>RNA, Viral--blood<br/>Ritonavir<br/>Thiazoles--adverse effects<br/>Treatment Outcome<br/>Valine--adverse effects